925P External validation of the CD8 radiomics signature as a prognostic marker in recurrent or metastatic head and neck cancer treated with nivolumab.

Autor:	Adrien, L.1 (AUTHOR), Even, C.2 (AUTHOR), Hano, J.B.1 (AUTHOR), Deny, N.1 (AUTHOR), Mitrea, D.3 (AUTHOR), Tao, Y.4 (AUTHOR), Lefebvre, G.5 (AUTHOR), Daste, A.6 (AUTHOR), Saada, E.B.7 (AUTHOR), Fayette, J.8 (AUTHOR), Blanchard, P.4 (AUTHOR), Cifliku, V.1 (AUTHOR), Talebi, F.1 (AUTHOR), Monard, L.9 (AUTHOR), Texier, M.10 (AUTHOR), Robert, C.1 (AUTHOR), Classe, M.11 (AUTHOR), Auperin, A.10 (AUTHOR), Deutsch, E.1 (AUTHOR), Sun, R.1 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 2, Vol. 35, pS646-S647. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu